期刊文献+

p53基因突变检测方法的演进和趋势 被引量:2

Evolution and trends of the detection methods for p53 gene mutation
下载PDF
导出
摘要 p53基因是肿瘤蛋白P53(tumor protein p53)的编码基因,在维持基因组稳定、调控细胞周期和凋亡及抑制肿瘤血管生成中发挥着重要的作用。p53基因突变信息在肿瘤分子筛查诊断、预防、药物疗法选择等方面具有重要的参考价值。本文分析了p53基因与P53蛋白突变检测的重要性、突变检测方法的发展概况,如传统的DNA测序、限制性片段长度多态性(restriction fragment length polymorphism,RFLP)、单链构像多态性(single-stranded conformation polymorphism,SSCP)等8类实验室常规基因突变检测策略及酵母中分离的等位基因功能分析技术(separation of gene function analysis in yeast,FASAY),近年来新兴的技术包括生物传感器、芯片、高分辨率溶解曲线(high resolution melting,HRM),及下一代测序技术,以期较为全面地展示现今p53及P53突变检测的整体情况,为p53或其他基因突变研究者选择突变检测方法提供参考。 p53 gene is the tumor protein P53-coding-gene. Tumor protein P53 plays important roles in keeping genomic stability, regulating and controlling cell cycle and cell apoptosis as well as suppressing angiogenesis of tumors. p53 gene mutation information can provide great reference value for molecular screening or diagnosis, prognosis of tumors and optimal choices in drugs or treatments, etc. By analyzing or introducing p53 gene and protein P53 and the importance of their mutation detection, development status of methods for their mutation detection, such as 8 categories of traditional and conventional laboratory methods including DNA sequencing, restriction fragment length polymorphism(RFLP), single-stranded conformation polymorphism(SSCP)and separation of gene function analysis in yeast(FASAY),and emerging technologies including bio-sensor chip, high resolution melting(HRM) and the next generation sequencing technology. This review may help readers quickly learn the overall situation of mutation detection of p53 and P53 and provide investigators with useful reference on the p53 and other gene mutation detection methods.
出处 《分子诊断与治疗杂志》 2016年第6期424-428,共5页 Journal of Molecular Diagnostics and Therapy
基金 基金项目:南方医科大学课外科研学术活动(2009kw109)
关键词 P53基因 突变检测 下一代测序 p53 gene Mutation detection Next generation sequencing
  • 相关文献

参考文献12

二级参考文献110

  • 1Francesca Faita,Cecilia Vecoli,Ilenia Foffa,Maria Grazia Andreassi.Next generation sequencing in cardiovascular diseases[J].World Journal of Cardiology,2012,4(10):288-295. 被引量:2
  • 2Kwok PY,Chen X.Detection of single nucleotide polymorphisms[J].Curr Issues Mol Biol,2003,5(2):43-60.
  • 3Yoon JH,Cho HI,Park SS,et al.Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria[J].J Clin Pathol,2002,55(6):410-413.
  • 4Lancaster JM,Berchuck A,Futreal PA,et al.Dideoxy fingerprinting assay for BRCA1 mutation analysis[J].Mol Carcinog,1997,19(3):176-179.
  • 5Lilleberg SL,Durocher J,Sanders C,et al.High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC,TP53,K-RAS,and BRAF genes with a novel DHPLC fluorescence detection platform[J].Ann N Y Ac ad Sci,2004,1022:250-256.
  • 6Knudson AG.Mutation and cancer:statistical study of retinoblastoma[J].Proc Natl Acad Sci U S A,1971,68(4):820-823.
  • 7Kurzawski G,Safranow K,Suchy J,et al.Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography[J].J Biochem Biophys Methods,2002,51 (1):89-100.
  • 8Gross E,Arnold N,Pfeifer K,et al.Identification of specific BRCA1and BRCA2 variants by DHPLC[J].Hum Mutat,2000,16(4):345-353.
  • 9Betz B,Florl AR,Seifert HH,et al.Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer[J].Hum Mutat,2004,23(6):612-620.
  • 10Jones AC,Sampson JR,Cheadle JP.Low level mosaicism detectable by DHPLC but not by direct sequencing[J].Hum Mutat,2001,17(3):233-234.

共引文献67

同被引文献11

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部